CMMB - Chemomab Therapeutics Ltd.

QQQ $ 434.89 $ 2.57 (0.59 %)

DIA $ 386.46 $ -0.28 (-0.07 %)

SPY $ 510.23 $ -0.30 (-0.06 %)

TLT $ 89.65 $ -0.46 (-0.51 %)

GLD $ 212.58 $ -0.77 (-0.36 %)

Previous Close

$ 0.7352

Open

$ 0.68

Bid

$ 0.69 x 100

Ask

$ 0.74 x 100

Day's Range

$ 0.68 - $ 0.71

52 Week Range

$ 0.42 - $ 1.89

Volume

12,208

Average Volume

Market Cap

172.77M

Beta (5Y Monthly)

$ 1.50

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-11-2023	03-31-2023	10-Q
2	03-20-2023	12-31-2022	10-K
3	11-10-2022	09-30-2022	10-Q
4	08-12-2022	06-30-2022	10-Q
5	05-12-2022	03-31-2022	10-Q
6	03-30-2022	12-31-2021	10-K
7	11-12-2021	09-30-2021	10-Q
8	08-13-2021	06-30-2021	10-Q
9	05-13-2021	03-31-2021	10-Q
10	03-09-2021	12-31-2020	10-K
11	11-16-2020	09-30-2020	10-Q
12	08-14-2020	06-30-2020	10-Q
13	05-07-2020	03-31-2020	10-Q
14	03-17-2020	12-31-2019	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Chemomab Reports New Peer-Reviewed Publica...
04/18/2024 11:11:35

Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), ...

Chemomab shares are trading higher after t...
03/25/2024 11:19:45

Chemomab Bagged New European Patent for CM...
03/25/2024 11:09:46

Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics...

Oppenheimer Maintains Perform on Chemomab ...
03/08/2024 13:45:49

Oppenheimer analyst Jeff Jones maintains Chemomab Therapeutics (NASDAQ:CMMB) from Perform to Perform.

Chemomab Therapeutics Q4 EPS $(0.26) Up Fr...
03/07/2024 12:06:29

Chemomab Therapeutics (NASDAQ:CMMB) reported quarterly losses of $(0.26) per share. This is a 63.89 percent increase over losse...

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
02/22/2024 13:05:56

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
02/21/2024 13:06:14

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
02/20/2024 21:31:12

whats-going-on-with-fibro-inflammatory-disease-focused-chemomab-therapeutics-on-tuesday

What's Going On With Fibro-Inflammatory Di...
02/20/2024 17:30:46

Chemomab Therapeutics' CM-101 granted new patents in Brazil and Israel, currently in Phase 2 SPRING trial for primary scler...

Chemomab Wins New Patents for CM-101, Its ...
02/20/2024 12:10:53

Chemomab Therapeutics Ltd. (NASDAQ:CMMB), (Chemomab), a clinical stage biotechnology company developing innovative therapeutic...

Chemomab Therapeutics Announced Publicatio...
01/30/2024 12:05:35

why-mdc-holdings-shares-are-trading-higher-by-around-17-here-are-20-stocks-moving-premarket

Why M.D.C. Holdings Shares Are Trading Hig...
01/18/2024 12:52:18

Shares of M.D.C. Holdings, Inc. (NYSE: MDC) rose sharply in today’s pre-market trading. Sekisui House, Ltd. and M.D.C. Holdi...

Chemomab Announces Completion Of Patient E...
01/03/2024 12:01:36

Roth MKM Reinstates Buy on Chemomab Therap...
12/19/2023 14:14:05

Roth MKM analyst Dylan Dupuis reinstates Chemomab Therapeutics (NASDAQ:CMMB) with a Buy and maintains $7 price target.

Why Children's Place Shares Are Trading Lo...
11/16/2023 18:11:41

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

Why Palo Alto Networks Shares Are Trading ...
11/16/2023 13:08:28

Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.

Chemomab Therapeutics Reported On Its Post...
11/16/2023 12:19:19

Crude Oil Falls 2%; TJX Issues Weak Earnin...
11/15/2023 19:30:32

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 150 points on Wednesday. The Dow tra...

why-shapeways-holdings-shares-are-trading-lower-by-around-20-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Why Shapeways Holdings Shares Are Trading ...
11/15/2023 19:04:31

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.